Aktis Oncology, Inc. (AKTS) Earnings Call Transcripts
About Aktis Oncology, Inc.
Aktis Oncology, Inc. (AKTS) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 21 calls on record spanning February 3, 2020 to September 16, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 21 Aktis Oncology, Inc. earnings call transcripts on record, spanning February 3, 2020 to September 16, 2026. Based on this history, Aktis Oncology, Inc. reports semi-annually. The most recent call on file is dated September 16, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AKTS
- Exchange
- NasdaqGS
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 21
- First call
- February 3, 2020
- Most recent
- September 16, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| Company Conference Presentations | Sep 16, 2026 | Read transcript → |
| Q3 FY2024 | May 13, 2024 | Read transcript → |
| Q2 FY2024 | Feb 13, 2024 | Read transcript → |
| Q1 FY2024 | Nov 13, 2023 | Read transcript → |
| Q4 FY2023 | Sep 6, 2023 | Read transcript → |
| Q3 FY2023 | May 8, 2023 | Read transcript → |
| Q2 FY2023 | Feb 7, 2023 | Read transcript → |
| M&A Calls | Jan 4, 2023 | Read transcript → |
| Q1 FY2023 | Nov 14, 2022 | Read transcript → |
| Q4 FY2022 | Sep 12, 2022 | Read transcript → |
| Q3 FY2022 | May 2, 2022 | Read transcript → |
| Q2 FY2022 | Jan 31, 2022 | Read transcript → |
| Q1 FY2022 | Nov 1, 2021 | Read transcript → |
| M&A Calls | Oct 18, 2021 | Read transcript → |
| Special Calls | Aug 30, 2021 | Read transcript → |
| Special Calls | May 3, 2021 | Read transcript → |
| Q2 FY2021 | Feb 1, 2021 | Read transcript → |
| Q1 FY2021 | Nov 2, 2020 | Read transcript → |
| Special Calls | Aug 24, 2020 | Read transcript → |
| Q3 FY2020 | May 4, 2020 | Read transcript → |
| Q2 FY2020 | Feb 3, 2020 | Read transcript → |